
Massive Russian earthquake struck on ‘megathrust fault'
With its epicentre near the city of Petropavlovsk-Kamchatsky, it was the biggest earthquake since the devastating Tohuku event in 2011, which caused a tsunami that sent Japan's Fukushima Daiichi nuclear plant into meltdown. 'The Kamchatka seismic zone is one of the most active subduction zones around the Pacific Ring of Fire, and the Pacific Plate is moving westwards at around 80 mm per year,' said Roger Musson, honorary research fellow at the British Geological Survey. 'Subduction' events, in which one plate pushes under another, are capable of generating far stronger earthquakes than 'strike slips', such as the one that hit Myanmar in March, where plates brush horizontally against one another at different speeds.
The Kamchatka area is particularly vulnerable and experienced a magnitude 9 event in November 1952, wiping out the town of Severo-Kurilsk and causing extensive damage as far away as Hawaii, Musson said. Shallow 'megathrust' events are more likely to cause tsunamis because they burst through the sea floor and displace huge volumes of water.
With a relatively shallow depth of 20.7 km, Wednesday's earthquake was always going to create such tsunami risks, experts said. 'It is an offshore earthquake and when you have offshore earthquakes there is the potential for tsunamis,' said Adam Pascal, chief scientist at Australia's Seismology Research Centre. 'If you have a relatively shallow earthquake it is more likely to rupture the surface of the ocean floor,' he added. 'We've seen in some cases you can have large earthquakes like this and not cause a tsunami because they are too deep and the shearing doesn't express itself at the surface.'
Tsunami waves of around 1.7 metres reached as far as Hawaii, less high than originally expected, but scientists warned that such waves do not have to be especially big to do damage to the relatively low-lying coastlines of Pacific island nations. Parts of French Polynesia were told to brace for waves as high as 4 metres.
The impact of a tsunami depends on its 'run-up' as it approaches coastlines, Pascal said. 'If you have a very long, shallow run-up to the coast, a lot of the energy can be dissipated over that run-up, but if it is a very steep shelf before you get to the coast, the wave height can be higher,' he said.
Wednesday's quake has already triggered at least 10 aftershocks above magnitude 5, and they could continue for months, said Caroline Orchiston, director of the Centre for Sustainability at the University of Otago in New Zealand. 'This demonstrates that large-magnitude earthquakes generate aftershock sequences that start immediately, and some of these can be damaging in their own right,' she said.
The 8.8 magnitude event on Wednesday came less than two weeks after a magnitude 7.4 earthquake in the same area, which has now been identified as a 'foreshock'. 'Earthquakes by their nature are unpredictable,' said Pascal. 'There are no precursors that are scientifically consistent in earthquake sequences. Before this morning, those other ones were the main shocks.'
Bigger aftershocks cannot entirely be ruled out, he added, but their magnitude and frequency normally tend to decrease over time. 'You can expect large aftershocks to continue for some time, but the frequency of large, damaging events will reduce as time goes on,' he said. 'There is always a chance of a larger event, but that larger event will usually occur relatively soon after, within days or weeks.' — Reuters
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Pharma interest can plug NIH funding gap: Illumina CEO
Genetic sequencing company Illumina (ILMN) has had a rough few years. It has battled activist investors, faced off with the Federal Trade Commission, and, most recently, agreed to a $9.8 million settlement with the Department of Justice over a cybersecurity breach. To add to the pile: sanctions in China and the Trump administration cutting National Institutes of Health (NIH) funding, which the company relies heavily on for clinical research. The numbers don't lie. The stock is down more than 21% in the past year and sank more than 11% in after-hours trading Thursday after the company reported an earnings miss for the second quarter. The company reported $1.06 billion in revenues compared to expected revenues of $1.05 billion. Adjusted earnings per share came in at $1.19 compared to estimates of $1.01. But CEO Jacob Thaysen told Yahoo Finance he remains positive about the company's near-term growth. Why? Because, in part, pharmaceutical companies can provide a new market. "Now, we're shifting from small things to really big programs. Some of the things making up for the reduction from the NIH is kind of indirect, but pharma is getting more interest in these big programs," he said, noting that 15% of the company is exposed to government research funding. "It's not only about sequencing itself, but really using massive amounts of data ... to really identify new drug targets and understand a disease," Thaysen said. The idea to use patient data to help the pharmaceutical world was also identified by 23andMe, which recently came out of bankruptcy through a nonprofit led by founder Anne Wojcicki. Thaysen said that unlike 23andMe, which he has worked with, his company is not going to pursue drug development on its own. "We have a lot of pharma companies that are very excited to work with us," he said. In addition to genetic testing of patient samples, the company is looking at growing in the preventative side of care with cancer screenings. The oncology business, Thaysen said, will have healthy growth over the next 10 or so years. China China banned importations of the San Diego-based company's sequencing machines earlier this year as part of its retaliatory actions to Trump's tariff war. Thaysen said he is working with regulators to try to reverse that, but "in the meantime, that business is declining, and we are expecting it to be flat." In fact, though China has historically been about 10% of the company's business, it contributed to half of the decline in earnings this past week. "China was never a huge part of Illumina's business. When it was the largest, it was just around 10%. We're down to 5% of the business," Thaysen told Yahoo Finance. But because of the tariff war and China's goals to boost its domestic innovation market, Illumina has faced a setback in its market power there from local competition. "As soon as there is a Chinese alternative that is good enough, then you will see that the Chinese government is pushing for the Chinese population, the Chinese companies to use that technology," Thaysen said. He added that even with the increased competition, China is an appealing market to remain in. Analysts are still waiting to see more progress on Illumina's return to growth. Jefferies analyst Tycho Peterson said in a note to clients that the firm will reiterate its Hold rating until things settle: "While the clinical traction is encouraging, we view clarity on near-term headwinds (A&G, China, Roche) and a path to sustainable HSD growth as key to a more constructive view. Reiterate Hold." Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Death of 9-year-old girl at Hersheypark ruled accidental, no criminal activity found
The death of a 9-year-old girl who drowned at Hersheypark has been ruled accidental, with no criminal activity found on the part of the park's employees, according to police. Sophia Subedi drowned on July 24 in the wave pool at the Pennsylvania theme park, the Derry Township Police Department said. A review by police concluded that the park upheld safety standards and that the number of people in the wave pool at the time was "significantly less than it's designed maximum capacity," according to a Derry Township Police statement released on Friday. MORE: 9-year-old dies at Hersheypark's water park in Pennsylvania Hersheypark had 10 lifeguards working specifically at the wave pool when Sophia drowned, the park said last month. "Witnesses and lifeguards responded promptly, initiating rescue and resuscitation efforts within seconds of noticing Sophia's distress," police said. "The Derry Township Police Department, along with the witnesses, Hersheypark staff, and first responders who attempted to save Sophia, extend their sincere condolences to her family and friends, as well as the Bhutanese community, during this difficult time." "Our hearts break for this child and the child's family. We extend our deepest condolences for their loss," John Lawn, Hersheypark's CEO, in a statement on July 24, adding that park-goers' "safety and well-being drive every decision we make."
Yahoo
22 minutes ago
- Yahoo
Agrify Corporation (AGFY) Raises $25.9M to Fuel THC Beverage Expansion
We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Agrify Corporation stands tenth on our list. Agrify Corporation (NASDAQ:AGFY) is transitioning from its roots in cultivation technology to a consumer-focused model centered on hemp-derived THC beverages. The company, known for its vertical farming units (VFUs) and cultivation software, recently sold its cultivation business and related assets to CP Acquisitions LLC, linked to former CEO Raymond Chang. This move allows the company to streamline operations and shift focus toward the rapidly growing THC beverage market. A key part of this pivot is the acquisition of Señorita, an award-winning hemp-derived THC beverage brand known for flavors like Mango Margarita and Lime Jalapeño Margarita. Distributed in nine U.S. states and Canada, the brand aligns with rising consumer interest in low-calorie, alcohol-free cannabis alternatives. Agrify Corporation (NASDAQ:AGFY) is increasingly mentioned among cheap pot stocks to buy due to its low market valuation and growth potential in this segment. The company plans to expand the product line with new offerings such as Paloma and Ranch Water. To support this new direction, the business raised $25.9 million in a private placement in late 2024, with Chairman and Interim CEO Ben Kovler personally participating, signaling leadership's confidence in the strategy. The funding will help scale beverage operations and explore additional cannabis product opportunities. Governance changes also reflect the company's new consumer focus. Peter Shapiro, with entertainment industry experience, and Sanjay Tolia, a cannabis investor, joined the board in early 2025, bringing expertise in branding and market growth. While we acknowledge the potential of AGFY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data